New Studies suggests which is more relevant to reduce risk of venous thromboembolism: Estradiol transdermal system or estrogen contraceptive pills
A New studies suggested a new hormonal therapy to reduce risk of venous thromboembolism than oral estrogen-only hormone therapy agents (contraceptive pills). In this study they compared Estradiol transdermal system with oral estrogen hormone therapy.